“…5,6 To achieve the desired therapeutic effect, PTAs are required with the following characteristics: (i) biosafety; (ii) strong nearinfrared (NIR) absorption (λ = 700-900 nm) for deep tissue penetration, preferably at 808 nm to coordinate with common PTT laser excitation; (iii) outstanding photostability; (iv) excellent photothermal conversion efficiency (PCE); and (v) favorable nonradiative transitions to generate heat. 1,7 In recent years, many kinds of inorganic PTAs have been developed vigorously, [8][9][10][11][12] including those based on gold nanostructures, 13 carbon materials, 14 quantum dots, 15 porous silicon, 16 and semiconductor nanoparticles. 17 In comparison with inorganic materials, a preponderance of organic PTAs (e.g., cyanine dyes, 18 porphyrins, 19 phthalocyanine, 20 diketopyrrolopyrroles, 7 BODIPY, 21 and benzobisthiadiazole 22 ), with properties such as flexible modification, satisfactory biocompatibility, low cytotoxicity, and fast body clearance, provide excellent prospects for clinical translation.…”